The inferno-framework/fhirpath-service provides a persistent service for
evaluating FHIRPath.
This lightweight wrapper enables applications not implemented in Java, such as
the Inferno Framework, to interface with
the FHIRPath in a service environment. It is primarily being used within
the Inferno Framework to provide HL7® FHIR® validation services for tests.
Since this is just a lightweight wrapper around the FHIRPathEngine, most of the functionality provided by this service is implemented within the HL7® FHIR® Core library, which is developed and maintained independently of this project.
The base FHIR R4 definitions are loaded during setup. No other IGs or FHIR versions are currently available.
See here for the REST API documentation.
System Requirements: The FHIRPath Service requires Java 11 or above.
To build and run the test suite:
./gradlew build check testgradlew.bat build check testTo run the app:
./gradlew runThe port can also be set through the environment
FHIRPATH_PORT=8080 ./gradlew runBuild
./build_docker.shRun
docker run -p 6789:6789 inferno_fhirpath_serviceAn uber jar can be created with:
./gradlew uberJarBy default, the uber jar will be located in build/lib/.
This uber jar can be executed with java -jar InfernoFHIRPathService-<version>-uber.jar
The Inferno development team can be reached by email at You may reach the team on the Inferno HL7 FHIR chat channel.
Copyright 2024 The MITRE Corporation
Licensed under the Apache License, Version 2.0 (the "License"); you may not use this file except in compliance with the License. You may obtain a copy of the License at
http://www.apache.org/licenses/LICENSE-2.0
Unless required by applicable law or agreed to in writing, software distributed under the License is distributed on an "AS IS" BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied. See the License for the specific language governing permissions and limitations under the License.
HL7, FHIR and the FHIR [FLAME DESIGN] are the registered trademarks of Health Level Seven International and their use does not constitute endorsement by HL7.